Baylor Research Institute, Swedish Orphan Biovitrum deal

Swedish Orphan received non-exclusive rights to Baylor’s patents covering the treatment of systemic onset juvenile idiopathic arthritis (sJIA) using IL-1 beta antagonists. The companies declined to di...